Status:
UNKNOWN
Evaluation of OCT and Visual Field Changes After Vitrectomy and ILM Peeling
Lead Sponsor:
Assiut University
Conditions:
ILM Peeling
Eligibility:
All Genders
Up to 80 years
Brief Summary
To evulate changes in VF and OCT after viterctomy associated with ILM peeling.
Detailed Description
Macular epiretinal membrane (ERM) is a disorder of the vitreomacular interface characterized by fibrocellular proliferation on the anterior surface of the internal limiting membrane (ILM) of the macula...
Eligibility Criteria
Inclusion
- 1-Idiopathic ERM,
- Primary full thickness macular hole,
- Lamellar macular hole, and
- Vitromacular traction.
Exclusion
- 1-Patients with a secondary ERM,
- diabetic retinopathy,
- venous occlusion,
- retinal detachment,
- uveitis, and
- trauma. 2-Other ocular pathologies that could interfere with the functional results
- <!-- -->
- dense cataract ,
- glaucoma, and
- previous retinal surgery.
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 8 2021
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04312620
Start Date
April 1 2020
End Date
April 8 2021
Last Update
March 18 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.